Xience

everolimus-eluting stent with permanent polymer · Abbott

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Xience, covering 2010-06-22 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions [NA]

See pricing